The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Modifying Orthobiological PRP Therapies Are Imperative for the Advancement of Treatment Outcomes in Musculoskeletal Pathologies
Open accessAbstract
Autologous biological cellular preparations have materialized as a growing area of medical advancement in interventional (orthopedic) practices and surgical interventions to provide an optimal tissue healing environment, particularly in tissues where standard healing is disrupted and repair and ultimately restoration of function is at risk. These cellular therapies are often referred to as orthobiologics and are derived from patient’s own tissues to prepare point of care platelet-rich plasma (PRP), bone marrow concentrate (BMC), and adipose tissue concentrate (ATC). Orthobiological preparations are biological materials comprised of a wide variety of cell populations, cytokines, growth factors, molecules, and signaling cells. They can modulate and influence many other resident cells after they have been administered in specific diseased microenvironments. Jointly, the various orthobiological cell preparations are proficient to counteract persistent inflammation, respond to catabolic reactions, and reinstate tissue homeostasis. Ultimately, precisely delivered orthobiologics with a proper dose and bioformulation will contribute to tissue repair. Progress has been made in understanding orthobiological technologies where the safety and relatively easy manipulation of orthobiological treatment tools has been demonstrated in clinical applications. Although more positive than negative patient outcome results have been registered in the literature, definitive and accepted standards to prepare specific cellular orthobiologics are still lacking. To promote significant and consistent clinical outcomes, we will present a review of methods for implementing dosing strategies, using bioformulations tailored to the pathoanatomic process of the tissue, and adopting variable preparation and injection volume policies. By optimizing the dose and specificity of orthobiologics, local cellular synergistic behavior will increase, potentially leading to better pain killing effects, effective immunomodulation, control of inflammation, and (neo) angiogenesis, ultimately contributing to functionally restored body movement patterns.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Platelet granular storages and their content in non-activated platelets. Electron microscopic scanning pictures of a cluster of platelets, at original magnification ×10,000. In (A), non-activated platelets from a PRP vial (PE) are shown. The ill-defined grey bodies represent the α-granules, approximately 50–80/platelet. The opaque round bodies are the dense granules, ranging from 0–30/platelet, and grey string-like bodies are lysosomes [24]. Thin lines signify platelet cell membranes. In (B), disrupted cell membranes are visible as activated platelets have released their granular contents (Abbreviations: ADP: adenosine diphosphate; ATP: adenosine triphosphate; TNF: tumor necrosis factor; 5-HT: serotonin; vWF: von Willebrand Factor; PDGF: platelet-derived growth factors; TGF: transforming growth factor; VEGF: vascular endothelial growth factor; FGF: fibroblast growth factor EGF: epidermal growth factor; CTGF: connective tissue growth factor; HGF: hepatocyte growth factor; KGF: keratinocyte growth factor; IGF: insulin-like growth factor; TIMP: Tissue inhibitor of metalloproteinase; MMP: matrix metalloproteases; F: coagulation factor; β-TG: beta-Thromboglobulin; NAP: neutrophil-activating peptide; MIP: Macrophage inflammatory protein; SDF: stromal cell derived factor; C: complement protein; Ig: Immunoglobulin). Adapted and modified from Everts et al. [3].](https://figures.cochat.ai/paper-figures/53cbbd54b5b44f1b8c44d5678ff76d88/modifying-orthobiological-prp-therapies-are-imperative-for-the-advancement-of-figure-1.jpg)
![Figure 2 Multicellular Density Separation after a Double-spin PRP Procedure. Graphical presentation of the cellular gravitational density separation using a 60 mL PurePRP-SP® device (Used with permission from EmCyte Corporation, Fort Myers, FL, USA). After the first spin (A), the whole blood is sequestered in a top layer (plasma fraction), an intermediate thin layer (multicomponent buffy coat, including platelets and leukocytes), and a bottom layer consisting of RBCs. After the second spin (B), all cells are concentrated at the bottom of the second compartment of the PRP device. In (C), after a magnification of the second compartment after the second spin, the multicellular buffy coat stratum (grey layer on top of the RBCs). Further enhancement, (D) picture, indicates the representation following cellular gravitational density separation, according to the specific densities of the individual cells [94]. Caveat: note the overlap in the range of cellular densities of the various cell types.](https://figures.cochat.ai/paper-figures/b20971dfa44e4ae7a84ace25ad95bee3/modifying-orthobiological-prp-therapies-are-imperative-for-the-advancement-of-figure-2.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PRP provides short-term symptomatic relief, particularly in tendon and ligament injuries, but variability in preparation limits its long-term efficacy [124,125].”
From Advancements in Regenerative Therapies for Orthopedics: A Comprehensive Review of Platelet-Rich Plasma, Mesenchymal Stem Cells, Peptide Therapies, and Biomimetic Applications (2025) · cites this paper as [124]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Wynn, T. A., & Vannella, K. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.015 · Cited by 4,481
Resolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552
Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood
Clark, S. R., Ma, A. C., Tavener, S. A., McDonald, B., Goodarzi, Z., Kelly, M. M., Patel, K. D., Chakrabarti, S., McAvoy, E., Sinclair, G. D., et al. (2007) · Nature Medicine · doi:10.1038/nm1565 · Cited by 2,309
From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
Italiani, P., & Boraschi, D. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00514 · Cited by 2,067
Polymeric system for dual growth factor delivery
Richardson, T. P., Peters, M. C., Ennett, A. B., & Mooney, D. J. (2001) · Nature Biotechnology · doi:10.1038/nbt1101-1029 · Cited by 1,752
Platelet-Rich Plasma (PRP): What Is PRP and What Is Not PRP?
Marx, R. E. (2001) · Implant Dentistry · doi:10.1097/00008505-200110000-00002 · Cited by 1,704
Lipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453
Prostaglandin Endoperoxides. Novel Transformations of Arachidonic Acid in Human Platelets
Hamberg, M., & Samuelsson, B. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.9.3400 · Cited by 1,407
Platelet α-granules: Basic biology and clinical correlates
Blair, P., & Flaumenhaft, R. (2009) · Blood Reviews · doi:10.1016/j.blre.2009.04.001 · Cited by 1,157
Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020
(2020) · doi:10.3390/ijms21207794 · Cited by 1,039
Self-citation
Cited by
Bensa, A., Previtali, D., Sangiorgio, A., Boffa, A., Salerno, M., & Filardo, G. (2025) · The American Journal of Sports Medicine · doi:10.1177/03635465241246524 · Cited by 137
Everts, P. A., Lana, J. F., Onishi, K., Buford, D., Peng, J. W., Mahmood, A., da Fonseca, L. F., van Zundert, A. A. J., & Podesta, L. (2023) · Biomedicines · doi:10.3390/biomedicines11071922 · Cited by 124
Self-citationEverts, P. A., Lana, J. F., Alexander, R. W., Dallo, I., Kon, E., Ambach, M. A., van Zundert, A. A. J., & Podesta, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147914 · Cited by 108
Self-citationBoffa, A., Marziani, L. D., Andriolo, L., Martino, A. D., Romandini, I., Zaffagnini, S., & Filardo, G. (2024) · The American Journal of Sports Medicine · doi:10.1177/03635465241283463 · Cited by 54
Systematic Review of Platelet-Rich Plasma for Low Back Pain
Machado, E. S., Soares, F. P., de Abreu, E. V., Souza, T. A. C., Meves, R., Grohs, H., Ambach, M. A., Navani, A. H., de Castro, R. B., Pozza, D. H., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11092404 · Cited by 51
Metadata
- Authors
- Everts, P. A., Mazzola, T., Mautner, K., Randelli, P. S., & Podesta, L.
- Affiliations
- Education & Research Division, Gulf Coast Biologics, Fort Myers, FL 33916, USA
- Breakthrough Regenerative Orthopedics, Boulder, CO 80305, USA
- Emory University (US)
- University of Milan (IT)
- Bluetail Medical Group, Naples, FL 34109, USA
- Corresponding author
- Everts, Peter A.
- Venue
- Biomedicines
- Publisher
- MDPI AG
- Published
- 2022-11-15
- Volume
- 10
- Issue
- 11
- Pages
- 2933
- ISSN
- 2227-9059 (ISSN-L)
- PMC
- PMC9687216
- OpenAlex
- W4309314212
- Cited by
- 34
- References
- 143
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 9 · 2023: 4
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomedicines (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Dentistry › Periodontics › Periodontal Regeneration and Treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Tendon Structure and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- platelet-rich plasma, orthobiologics, bone marrow aspirate concentrate, autologous cell therapy, musculoskeletal disorders, PRP preparation methods, bioformulation, dosing regimen, injection volume, inflammation modulation, angiogenesis, tissue repair
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modifying Orthobiological PRP Therapies Are Imperative for the Advancement of Treatment Outcomes in Musculoskeletal Pathologies. https://app.cochat.ai/papers/10.3390/biomedicines10112933
- The paper
- Everts, P. A., Mazzola, T., Mautner, K., Randelli, P. S., & Podesta, L. (2022). Modifying Orthobiological PRP Therapies Are Imperative for the Advancement of Treatment Outcomes in Musculoskeletal Pathologies. Biomedicines. https://doi.org/10.3390/biomedicines10112933
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.